Tempus Agreement (Additional Information) (Details) - Tempus Agreement $ / shares in Units, $ in Millions		3 Months Ended
	Nov. 25, 2023 USD ($)	Mar. 31, 2024 USD ($) Warrants	Nov. 28, 2023 $ / shares shares
Tempus Agreement [LineItems]
Market Development Fees		$ 6.0
Activation fees	$ 3.0	3.0
First milestone payments upon achievement of specified clinical validations	3.0
Second milestone fees payable subject to achieving two additial clinical validations	6.0
Fair market value of promotional and commercialization services	9.6
First Milestone Fee		$ 3.0
Number of warrants | Warrants		2
Decrease in fair value of warrants		$ (4.8)
Maximum
Tempus Agreement [LineItems]
Market Development Fees	$ 12.0
Percentage of its gross revenues attributable to such license	20.00%
Minimum
Tempus Agreement [LineItems]
Percentage of its gross revenues attributable to such license	10.00%
Other Nonoperating Income (Expense)
Tempus Agreement [LineItems]
Warrant gain recognized		4.8
Tempus Warrants
Tempus Agreement [LineItems]
Proceeds from issuance of warrants		6.0
Market development fees payable		$ 6.0
Warrant exercise price per share | $ / shares			$ 2.5
Warrant expiration date			Dec. 31, 2025
Tempus Warrants | Maximum
Tempus Agreement [LineItems]
Warrant issued to purchase stock | shares			4,609,400
First Warrant
Tempus Agreement [LineItems]
Warrant exercise price per share | $ / shares			$ 1.5
Warrant expiration date			Dec. 31, 2024
First Warrant | Maximum
Tempus Agreement [LineItems]
Warrant issued to purchase stock | shares			4,609,400